Heart Valve Devices | Europe | 2017 | Market Analysis
The European market for heart valve devices will grow through 2025 as a result of rising adoption of THV devices; in particular, improvements to TAVR devices and emerging TMVR devices will drive cannibalization of surgical procedures.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Europe across a 10-year period.
TMVI devices are emerging in the European market.
When are TMVI devices expected to enter the European market?
How will uptake of TMVI devices compare to that of TAVR devices?
The European heart valve device market is dominated by four entrenched competitors, although several other companies are developing THV technology.
In which market segments do new devices have the greatest opportunity to compete successfully?
What advantages do the entrenched competitors have in the market?
Is new THV technology iterative, or will it have a transformational effect on the market?
Tissue heart valves and annuloplasty repair devices face competition from THV devices.
When will various transcatheter devices enter the market?
How will new transcatheter technologies affect the surgical repair and replacement device markets?
Will transcatheter mitral valve replacement and repair devices experience the same adoption as TAVR devices?
